THE TECHNOLOGY
The use of Space Technology to improve circulation and recovery
LymphaCARE Intermittent Vacuum Therapy (IVT) technology was introduced in 1968, contributed to the health and to avoid orthostatic complications of the astronauts. Today, people around the world gained health benefits and results from this unique technology.
It all started in 1962, where the permanent negative pressure in a range to -70mbar.
|
Why the need to have such technology? Because the absence of gravity in space leads to orthostatic complications and complications of the baroreceptor reflex.
Scientist Astronaut, Owen K. Gariott in the LBNPD in July - September 1973.
|
Astronaut Jack R. Lousma, Skylab 3 Pilot, in the LBNPD.
Lower Body Negative Pressure Device (L.B.N.P.D.) applies the alternating negative pressure (vacuum) and positive pressure to the lower extremities up to the abdominal.
|
|
The technological origin of IVT lies in the space medicine of the American NASA. In the weightlessness of the orbit the astronauts have to undergo a negative pressure treatment in an LBNPD (Lower Body Negative Pressure Device) every ten hours to avoid orthostatic complications. This is the only way to ensure sufficient blood circulation in the lower extremities in spite of a lack of gravity. The further development of the LBNPD is the LymphaCARE System. The device was developed at the Institute for Space Medicine of the Germany Aerospace Centre (DLR). The main areas of use are cardio-vascular stimulation and revascularisation. IVT is also recognised as a modern, cost-effective therapy for lymph and lipo oedemas. In a different form the method is also used to boost post-traumatic or post-operative rehabilitation or as pain therapy for the arms, neck and shoulders (LymphaCARE® A.N.S. device). High tolerance, high patient benefit and the positive effect on the profitability of the medical facility are documented.
|
|
|
|
|
